+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
HIV or AIDS Diagnostics Market by Test Type (Antibody Tests, CD4 Tests, Viral Load Tests), Type of Product (Consumables & Reagents, Instruments & Kits, Software), Testing Method, End-User, Application - Global Forecast 2025-2030- Product Image
HIV or AIDS Diagnostics Market by Test Type (Antibody Tests, CD4 Tests, Viral Load Tests), Type of Product (Consumables & Reagents, Instruments & Kits, Software), Testing Method, End-User, Application - Global Forecast 2025-2030- Product Image
Sale

HIV or AIDS Diagnostics Market by Test Type (Antibody Tests, CD4 Tests, Viral Load Tests), Type of Product (Consumables & Reagents, Instruments & Kits, Software), Testing Method, End-User, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904396
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The HIV and AIDS Diagnostics Market continues to evolve rapidly, shaped by advances in clinical needs, regulatory changes, and integration of digital health technologies. For senior leaders, navigating this landscape means understanding the nuanced interplay of innovation, cost structures, and emerging care models driving competitive differentiation and sustainable growth.

Market Snapshot: HIV and AIDS Diagnostics Market Overview

The HIV and AIDS Diagnostics Market grew from USD 2.45 billion in 2024 to USD 2.60 billion in 2025. It is expected to continue growing at a CAGR of 6.34%, reaching USD 3.54 billion by 2030. This positive trajectory reflects the market’s response to ongoing clinical imperatives, rapid technology adoption, and shifting policies. Market momentum is underpinned by increased investment in diagnostic innovation and partnerships across organizations focused on enhancing detection accuracy, expanding patient access, and supporting real-time data-driven care models. Ongoing regional initiatives and modernization of testing workflows are creating new opportunities for established players and emerging innovators alike.

Scope & Segmentation

  • Test Types: Includes antibody tests (ELISA/EIA, rapid tests, Western Blot), CD4 tests, and viral load tests.
  • Product Categories: Encompasses consumables and reagents, instruments and kits, software, and comprehensive testing services.
  • Testing Methods: Covers laboratory-based testing, point-of-care testing, and self-testing applications.
  • End-User Demographics: Incorporates blood banks, transfusion centers, diagnostic centers, home care settings, hospitals, clinics, and research institutes.
  • Clinical Applications: Spans disease progression, therapeutic monitoring, and screening initiatives.
  • Regional Coverage: Analyzes market activity and policy environments in the Americas, Europe, Middle East & Africa, and Asia-Pacific, including key national markets such as the United States, China, India, Germany, Brazil, and South Africa.
  • Company Coverage: Profiles major market participants, encompassing both established manufacturers and emerging innovators.

Key Takeaways for Decision-Makers

  • Technological advancements are shortening diagnosis windows and enabling more precise therapeutic monitoring through point-of-care and molecular platforms across diverse settings.
  • Regulatory shifts increasingly prioritize fast-tracking diagnostics with demonstrable clinical value, while aligning approval processes with evolving public health objectives.
  • Digital integration and data connectivity are transforming workflows by enabling real-time result reporting, streamlined patient pathways, and improved quality assurance.
  • Market segmentation by test, product, end-user, and application drives strategic targeting, fostering both innovation and operational agility among leading firms.
  • Collaborative alliances and cross-sector consortia are shaping the pace and direction of research, development, and commercial deployment within the industry.
  • Strategic focus on supply chain resilience, automation, and modular assay design ensures operational continuity amid regulatory and geopolitical uncertainty.

Tariff Impact: Navigating US Import Measures in 2025

In 2025, new US tariffs on reagents, instruments, and imported consumables are recalibrating supply chains across the HIV and AIDS diagnostics sector. These measures have increased cost pressures for manufacturers and healthcare providers, prompting greater attention to alternative sourcing, domestic production, and regional manufacturing partnerships. As a result, value chain participants are optimizing procurement strategies, renegotiating supplier agreements, and investing in production flexibility. Collaborative ventures and resource pooling are emerging to absorb costs and maintain market responsiveness. The ongoing tariff environment also highlights the need for agile operating models to offset localized expense fluctuations and sustain service quality for diagnostic clients nationwide.

Methodology & Data Sources

This research leverages comprehensive methodologies combining direct consultations with clinical laboratorians, infectious disease specialists, and procurement leaders. Rigorously validated secondary data from regulatory filings, peer-reviewed publications, and industry white papers supports evidence-based analysis. Expert panel input and triangulation techniques are used to ensure quality, accuracy, and objectivity throughout trend evaluation and technology assessment.

Why This Report Matters for Leaders in HIV and AIDS Diagnostics

  • Enables informed decision-making with robust segmentation insights and actionable market intelligence tailored to evolving stakeholder needs.
  • Empowers leaders to anticipate regulatory and supply chain disruptions by mapping operational and competitive landscapes across major regions and user categories.
  • Supports strategic planning by highlighting the role of digital tools, collaborative networks, and agile manufacturing in shaping sustainable market growth and patient outcomes.

Conclusion

Senior executives gain a comprehensive view of transformative trends, strategic imperatives, and actionable pathways in HIV and AIDS diagnostics. The report equips decision-makers to adapt business strategies, prioritize investments, and capture growth in a rapidly evolving global healthcare environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of point-of-care HIV self-testing kits with mobile health apps to improve patient linkage to care
5.2. Adoption of CRISPR-based diagnostics for rapid ultra-sensitive HIV viral load quantification in decentralized settings
5.3. Impact of fourth generation combination antigen antibody assays on early acute HIV infection detection
5.4. Expansion of multiplex PCR panels enabling simultaneous detection of HIV hepatitis C and tuberculosis co-infection in a single assay
5.5. Emerging use of AI powered image analysis in flow cytometry for automated CD4 T cell enumeration in HIV monitoring
5.6. Development of multi omics biomarker panels integrating proteomics metabolomics and transcriptomics for HIV disease progression stratification
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. HIV or AIDS Diagnostics Market, by Test Type
8.1. Introduction
8.2. Antibody Tests
8.2.1. ELISA/EIA
8.2.2. Rapid Tests
8.2.3. Western Blot Test
8.3. CD4 Tests
8.4. Viral Load Tests
9. HIV or AIDS Diagnostics Market, by Type of Product
9.1. Introduction
9.2. Consumables & Reagents
9.3. Instruments & Kits
9.4. Software
9.5. Testing Services
10. HIV or AIDS Diagnostics Market, by Testing Method
10.1. Introduction
10.2. Laboratory-Based Testing
10.3. Point-Of-Care Testing
10.4. Self-Testing
11. HIV or AIDS Diagnostics Market, by End-User
11.1. Introduction
11.2. Blood Banks & Transfusion Centers
11.3. Diagnostic Centers
11.4. Home Care Settings
11.5. Hospitals & Clinics
11.6. Research Institutes
12. HIV or AIDS Diagnostics Market, by Application
12.1. Introduction
12.2. Disease Progression
12.3. Monitoring
12.4. Screening
13. Americas HIV or AIDS Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa HIV or AIDS Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific HIV or AIDS Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. F. Hoffmann-La Roche Ltd.
16.3.3. ACON Laboratories
16.3.4. Beckman Coulter, Inc.
16.3.5. Becton, Dickinson and Company
16.3.6. Bio-Rad Laboratories
16.3.7. bioMérieux SA
16.3.8. Chembio Diagnostics, Inc.
16.3.9. Danaher Corporation
16.3.10. DiaSorin S.p.A.
16.3.11. ELITechGroup
16.3.12. Euroimmun Medizinische Labordiagnostika AG
16.3.13. Hologic, Inc.
16.3.14. InBios International, Inc.
16.3.15. OraSure Technologies
16.3.16. Ortho Clinical Diagnostics, Inc.
16.3.17. SD Biosensor Inc.
16.3.18. Siemens Healthineers AG
16.3.19. Thermo Fisher Scientific, Inc.
16.3.20. Trinity Biotech plc
16.3.21. Viracor Eurofins Diagnostic Services
16.3.22. Wondfo Biotech Co. Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. HIV OR AIDS DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. HIV OR AIDS DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. HIV OR AIDS DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. HIV OR AIDS DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. HIV OR AIDS DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. HIV OR AIDS DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. HIV OR AIDS DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HIV OR AIDS DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA/EIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ELISA/EIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RAPID TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY WESTERN BLOT TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CD4 TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CD4 TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY VIRAL LOAD TESTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS & KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY LABORATORY-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY LABORATORY-BASED TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SELF-TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SELF-TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY BLOOD BANKS & TRANSFUSION CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY BLOOD BANKS & TRANSFUSION CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DISEASE PROGRESSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY DISEASE PROGRESSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 92. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 93. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 94. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 95. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 96. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 97. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 98. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 99. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 100. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 101. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 102. CANADA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 103. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 104. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 105. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 106. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 107. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 108. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 109. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 110. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 111. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 112. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 113. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 114. MEXICO HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 159. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 160. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 161. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 166. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 167. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 168. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 169. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 172. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 173. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. GERMANY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 178. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 179. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 180. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 181. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 182. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 183. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 184. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 185. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. FRANCE HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 195. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 196. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 197. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 198. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 199. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. RUSSIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 204. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 205. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 206. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 207. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 208. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 209. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ITALY HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 214. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 215. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 216. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 217. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 218. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 219. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 220. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 221. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 222. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 223. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 224. SPAIN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 233. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. UNITED ARAB EMIRATES HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 244. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 245. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 246. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 248. SAUDI ARABIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 256. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 260. SOUTH AFRICA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 261. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 262. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 263. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 264. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 265. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 266. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 267. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 268. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 269. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 270. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 271. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 272. DENMARK HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 279. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 280. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 281. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 282. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 283. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. NETHERLANDS HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 286. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 287. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 288. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 289. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 290. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 291. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 292. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 293. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. QATAR HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 298. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 299. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 300. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 301. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 302. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 303. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 304. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 305. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 306. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 307. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 308. FINLAND HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 315. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 316. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD MILLION)
TABLE 317. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 318. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 319. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 320. SWEDEN HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY ANTIBODY TESTS, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TYPE OF PRODUCT, 2025-2030 (USD MILLION)
TABLE 327. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2018-2024 (USD MILLION)
TABLE 328. NIGERIA HIV OR AIDS DIAGNOSTICS MARKET SIZE, BY TESTING METHOD, 2025-2030 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • ACON Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • bioMérieux SA
  • Chembio Diagnostics, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • ELITechGroup
  • Euroimmun Medizinische Labordiagnostika AG
  • Hologic, Inc.
  • InBios International, Inc.
  • OraSure Technologies
  • Ortho Clinical Diagnostics, Inc.
  • SD Biosensor Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech plc
  • Viracor Eurofins Diagnostic Services
  • Wondfo Biotech Co. Ltd.

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.6 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.54 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned22

Related Topics

Related Reports

HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030 - Product Image

HIV Diagnostics Market by Product (Assay Kits & Reagents, Instrument, Software), Test Type (Rapid Test, ELISA, Western Blot, Viral Load, CD4 Test), End User (Diagnostic Laboratories, Homecare Settings, Hospital) - Global Forecast to 2030

  • Report
  • 274 Pages
  • Global
From
HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F - Product Image

HIV Diagnostics Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
HIV/AIDS Testing - Global Strategic Business Report - Product Image

HIV/AIDS Testing - Global Strategic Business Report

  • Report
  • 202 Pages
  • Global
From
HIV Diagnostics - Company Evaluation Report, 2025 - Product Image

HIV Diagnostics - Company Evaluation Report, 2025

  • Report
  • 105 Pages
  • Global
From
HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033 - Product Image

HIV Drugs Market Size, Share, Trends and Forecast by Drug Class, Distribution Channel, and Region, 2025-2033

  • Report
  • 138 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.